Moreover, PCSK9 deficiency failed to retard tumor growth in mice depleted of CD8+ T cells, while depletion of CD4+ T cells had hardly any impact, which led CD8+ cytotoxic T cells (CTLs) to be identified as the most critical for the anti-tumor effect of PCSK9 deficiency. Here, CD4 is linked to neoplasm.